Safety and Treatment Experience With Sodium/glucose Cotransporter-2 Inhibitors in Adult Patients With Congenital Heart Disease
Authors:
- 31 March 2023
- journal article
- letter
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 29 (6) , 974-975
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- The First Experience with Sodium-Glucose Cotransporter 2 Inhibitor for the Treatment of Systemic Right Ventricular FailureESC Heart Failure, 2022
- Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular DiseaseJACC, 2021
- Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trialsThe Lancet, 2020
- Contemporary Hospitalization Rate Among Adults With Complex Congenital Heart DiseaseWorld Journal for Pediatric and Congenital Heart Surgery, 2016